Cálculo de los tiempos de circularvección en una población con patología vestibular. Influencia del estímulo visual

[corrected] To describe the results obtained for circularvection times (tCV) in a study of the phenomenon of visual-vestibular interaction for a population with vestibular pathology and to analyze differences in its calculation among patients reporting a worsening of their symptoms with visual stimuli. MATERIAL AND METHODS: A detailed case history was taken for all patients, followed by a sensory organization test using computerized dynamic posturography and the calculation of their tCV. RESULTS: The mean tCV results were: tCV2= 6.32+/-3.17 s; tCV3=6.57+/-3.68 s; tCVr=6.27+/-6.02 s. Significant differences were obtained in tCV2 (P=.046) and tCVr (P=.023). CONCLUSIONS: tCV is a diagnostic test using simple tools that can help differentiate patients in whom the visual stimulus is influenced

Absence of static phase separation in the high-Tc cuprate YBa2Cu3O6+yYBa_{2}Cu_{3}O_{6+y}

We use 89Y NMR in $YBa_{2}Cu_{3}O_{6+y}$ in order to evaluate with high sensitivity the distribution of hole content p in the CuO2 planes. For y=1 and y=0.6, this hole doping distribution is found narrow with a full width at half maximum smaller than Delta p=0.025. This rules out any large static phase separation between underdoped and optimally doped regions in contrast with the one observed by STM in Bi2212 and by NQR in LaSrCuO. This establishes that static electronic phase separation is not a generic feature of the cuprates.Comment: published in Phys.Rev.Lett. 89, 157002 (2002) (only minor changes as compared to previous version) Article of 4 pages + 3 figure

Detection of (1,3)-β-d-Glucan in Cerebrospinal Fluid in Histoplasma Meningitis

The diagnosis of central nervous system (CNS) histoplasmosis is often difficult. Although cerebrospinal fluid (CSF) (1,3)-β-d-glucan (BDG) is available as a biological marker for the diagnosis of fungal meningitis, there are limited data on its use for the diagnosis of Histoplasma meningitis. We evaluated CSF BDG detection, using the Fungitell assay, in patients with CNS histoplasmosis and controls. A total of 47 cases and 153 controls were identified. The control group included 13 patients with a CNS fungal infection other than histoplasmosis. Forty-nine percent of patients with CNS histoplasmosis and 43.8% of controls were immunocompromised. The median CSF BDG level was 85 pg/ml for cases, compared to <31 pg/ml for all controls (P < 0.05) and 82 pg/ml for controls with other causes of fungal meningitis (P = 0.27). The sensitivity for detection of BDG in CSF was 53.2%, whereas the specificity was 86.9% versus all controls and 46% versus other CNS fungal infections. CSF BDG levels of ≥80 pg/ml are neither sensitive nor specific to support a diagnosis of Histoplasma meningitis

Manejo De Residuos Sólidos Hospitalarios En La Unidad Oncológica Solca-Chimborazo

It was determined that the handling of the solid waste generated by the SOLCA – Chimborazo cancer hospital was not appropriate, both internally and externally. Because of that, the classification, transport, storage, deactivation, and intermediate disposition are inconvenient. Thus, it was realized that it is important to have the requirements and documents to follow and comply the objectives that are specified within the management, focusing on feedback and continuous improvement. To learn about the nature of the generated residuals, they were characterized in the hospital. Common, infectious, radioactive, organic and sharp residuals were found during the months of September, November and December. The common waste is comprised of cardboard, paper and plastic. The per-capita production of residuals was 0.76 kg/patient/day. The environmental impact caused by the generation of hospital solid waste was 56% severe impacts and 44% moderate impacts, which could elicit health problems in the population surrounding the hospital. For this reason, the appropriate management of solid waste allowed to obtain large environmental benefits and reduce the pollution generated by the hospital solid waste. It is recommended to SOLCA-Chimborazo and other health institutions the implementation of an adequate solid waste management, which will allow them to comply with all the requirements enforced by the environmental regulations

Economic and full environmental assessment of electrofuels via electrolysis and co-electrolysis considering externalities

Electrofuels from CO2 and H2O have recently emerged as a promising alternative to reduce the carbon footprint of fossil fuels, yet their full economic and environmental performance remains unclear. Here, the production of renewable petrol from electrolysis and co-electrolysis-based processes is critically assessed, combining a palette of tools encompassing process simulation, costing evaluation, life-cycle assessment, and uncertainty analysis. Our results show that electrofuels are currently very expensive (10.4-fold higher cost compared to petrol), even when considering externalities (indirect cost of environmental impacts). Electrofuels could become cheaper than the fossil analogue, yet this would require relying on low-cost renewable electricity, which may find alternative uses. From an environmental perspective, we found that despite reducing the carbon footprint of the fossil counterpart, electrofuels could exacerbate impacts on human health due to burden-shifting. Overall, our work highlights the need to embrace impacts beyond climate change to ensure a comprehensive assessment of alternative fuels, and to monetise them to underpin a fair comparison with the fossil analogue

Barley β-glucan accelerates wound healing by favoring migration versus proliferation of human dermal fibroblasts

β-Glucans are considered candidates for the medication in different human pathologies. In this work, we have purified β-glucan from a selected barley line and tested their effects in primary human dermal fibroblasts. Unexpectedly, we have observed that this compound promoted a short-transitory proliferation arrest at 24 h after its addition on the medium. We have determined that this transitory arrest was dependent on the cell-cycle regulator protein Retinoblastoma. Moreover, dermal fibroblasts increase their migration capacities at 24 h after barley β-glucan addition. Also, we have described that barley β-glucan strongly reduced the ability of fibroblasts to attach and to spread on cell plates. Our data indicates that barley β-glucan signal induces an early response in HDF cells favoring migration versus proliferation. This feature is consistent with our observation that the topical addition of our barley β-glucan in vivo accelerates the wound closure in mouse skin

Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry

Totes les malalties cerebrovasculars/ictus; Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Trombosi venosa cerebralTodas las enfermedades cerebrovasculares/ictus; Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Trombosis venosa cerebralAll cerebrovascular diseases/stroke; Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Cerebral venous thrombosisBackground Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has been associated with a significant risk of thrombotic events in critically ill patients. Aim To summarize the findings of a multinational observational cohort of patients with SARS-CoV-2 and cerebrovascular disease. Methods Retrospective observational cohort of consecutive adults evaluated in the emergency department and/or admitted with coronavirus disease 2019 (COVID-19) across 31 hospitals in four countries (1 February 2020–16 June 2020). The primary outcome was the incidence rate of cerebrovascular events, inclusive of acute ischemic stroke, intracranial hemorrhages (ICH), and cortical vein and/or sinus thrombosis (CVST). Results Of the 14,483 patients with laboratory-confirmed SARS-CoV-2, 172 were diagnosed with an acute cerebrovascular event (1.13% of cohort; 1130/100,000 patients, 95%CI 970–1320/100,000), 68/171 (40.5%) were female and 96/172 (55.8%) were between the ages 60 and 79 years. Of these, 156 had acute ischemic stroke (1.08%; 1080/100,000 95%CI 920–1260/100,000), 28 ICH (0.19%; 190/100,000 95%CI 130–280/100,000), and 3 with CVST (0.02%; 20/100,000, 95%CI 4–60/100,000). The in-hospital mortality rate for SARS-CoV-2-associated stroke was 38.1% and for ICH 58.3%. After adjusting for clustering by site and age, baseline stroke severity, and all predictors of in-hospital mortality found in univariate regression (p < 0.1: male sex, tobacco use, arrival by emergency medical services, lower platelet and lymphocyte counts, and intracranial occlusion), cryptogenic stroke mechanism (aOR 5.01, 95%CI 1.63–15.44, p < 0.01), older age (aOR 1.78, 95%CI 1.07–2.94, p = 0.03), and lower lymphocyte count on admission (aOR 0.58, 95%CI 0.34–0.98, p = 0.04) were the only independent predictors of mortality among patients with stroke and COVID-19. Conclusions COVID-19 is associated with a small but significant risk of clinically relevant cerebrovascular events, particularly ischemic stroke. The mortality rate is high for COVID-19-associated cerebrovascular complications; therefore, aggressive monitoring and early intervention should be pursued to mitigate poor outcomes.The author(s) received no financial support for the research, authorship, and/or publication of this article

Machine Learning Analysis of Individual Tumor Lesions in Four Metastatic Colorectal Cancer Clinical Studies: Linking Tumor Heterogeneity to Overall Survival

Total tumor size (TS) metrics used in TS models in oncology do not consider tumor heterogeneity, which could help to better predict drug efficacy. We analyzed individual target lesions (iTLs) of patients with metastatic colorectal carcinoma (mCRC) to determine differences in TS dynamics by using the ClassIfication Clustering of Individual Lesions (CICIL) methodology. Results from subgroup analyses comparing genetic mutations and TS metrics were assessed and applied to survival analyses. Data from four mCRC clinical studies were analyzed (1781 patients, 6369 iTLs). CICIL was used to assess differences in lesion TS dynamics within a tissue (intra-class) or across different tissues (inter-class). First, lesions were automatically classified based on their location. Cross-correlation coefficients (CCs) determined if each pair of lesions followed similar or opposite dynamics. Finally, CCs were grouped by using the K-means clustering method. Heterogeneity in tumor dynamics was lower in the intra-class analysis than in the inter-class analysis for patients receiving cetuximab. More tumor heterogeneity was found in KRAS mutated patients compared to KRAS wild-type (KRASwt) patients and when using sum of longest diameters versus sum of products of diameters. Tumor heterogeneity quantified as the median patient’s CC was found to be a predictor of overall survival (OS) (HR = 1.44, 95% CI 1.08–1.92), especially in KRASwt patients. Intra- and inter-tumor tissue heterogeneities were assessed with CICIL. Derived metrics of heterogeneity were found to be a predictor of OS time. Considering differences between lesions’ TS dynamics could improve oncology models in favor of a better prediction of OS

The longitudinal structure function F_L: perturbative QCD and k_T-factorization versus experimental data at fixed W

We use results for the structure functions $F_L$ for a gluon target having nonzero transverse momentum square at order $\alpha_s$, obtained in our previous paper, to compare with recent H1 experimental data for $F_L$ at fixwd W values and with collinear GRV predictions at LO and NLO approximation.Comment: 10 pages, 4 figure

Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases

ω3-polyunsaturated free fatty acids (ω3-PUFAs), particularly docosahexaenoic (DHA) and eicosapentaenoic acid (EPA), are thought to exert health promoting effects in metabolic and in inflammatory diseases. The molecular mechanisms of these beneficial effects are only partially understood. DHA and EPA activate Free Fatty Acid receptor 4 (GPR120/FFA4). Recently, the first orally available, synthetic ligand of FFA4, 3-[2-chloro-5-(trifluoromethoxy)phenyl]-3-azaspiro[5.5]undecane-9-acetic acid ("compound A"; cpd A) has been developed. Cpd A exhibits distinctly higher potency, efficiency, and selectivity at FFA4 than ω3-PUFAs and ameliorates insulin resistance and adipose tissue inflammation in the mouse. With GPR120/FFA4 activation believed to also attenuate tissue inflammation in autoimmune diseases, cpd A may also have a beneficial effect in these diseases. We have therefore addressed the therapeutic potential of cpd A in mouse models of three prototypical autoimmune diseases, specifically psoriasis, rheumatoid arthritis, and bullous pemphigoid. The effect of cpd A on the course of Aldara™-induced psoriasis-like dermatitis, K/BxN serum transfer arthritis, and antibody transfer pemphigoid disease-like dermatitis was scrutinized. Cpd A did not alter the course of Aldara-induced psoriasis-like dermatitis, K/BxN serum transfer arthritis, or antibody transfer pemphigoid disease-like dermatitis. Our results suggest that therapeutic regimens solely relying on FFA4 activation do not bear the potential to treat inflammatory diseases. With cpd A distinctly more potent in activating GPR120/FFA4 than ω3-PUFAs, this also suggests that GPR120/FFA4 activation by ω3-PUFAs does not significantly contribute to the health-promoting effects of ω3-PUFAs in autoimmune diseases